Gradiant

035080 · KOSDAQ · ₩035080 · 그래디언트

₩11,330▼ ₩150 (1.31%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −13.51%
Market cap
₩127B
Enterprise value
₩159B
P/E
—
P/B
0.3×
Dividend yield
1.8%
ROE
−4.4%
Net margin
−0.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−25.9% from the high

₩7,220Today: ₩11,110 – ₩11,660₩15,300

Returns

  • 1W−1.8%
  • 1M−1.3%
  • 3M+22.4%
  • 6M−6.4%
  • YTD−0.7%
  • 1Y−13.5%
Volume today
19,196
0.7× the 20-day average
Traded today
₩216M
Listed shares
11,174,129
EPS (12 months)
−₩1,763
Earnings yield −15.6%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

38Quiet
  • BuzzQuietBuzz 38 of 100 (50 is a normal day for this stock).
  • MomentumFlat-2.9% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Gradiant stock overview

Gradiant (그래디언트, KRX: 035080) is listed on KOSDAQ, in the Retail & Trade sector. The company is a Korean holding-type business that supports and manages its subsidiaries and develops, manufactures and sells health functional foods. Its shares closed at ₩11,330 on Oct 30, 2026, down 1.31% on the day, giving it a market value of ₩127B.

Key facts

Market cap
₩127B
Sector
Retail & Trade
Latest price change
−1.31%
As of
Oct 30, 2026
Main business
The company is a Korean holding-type business that supports and manages its subsidiaries and develops, manufactures and sells health functional foods.

Quick answers about Gradiant

What does Gradiant do?
The company is a Korean holding-type business that supports and manages its subsidiaries and develops, manufactures and sells health functional foods. Its main segments are a holding business, industrial B2B e-commerce through brands such as iMarket Korea and Cube Bridge (selling consumables, raw materials, building materials and IT products), biohealthcare (prescription drugs and medical supplies through subsidiaries such as Ahn-Yeon Care and Terapex), and other businesses including logistics services. Its consolidated operations span Korea, Vietnam, China and other markets.
What is the market cap of Gradiant?
The market capitalisation of Gradiant was ₩127B at the close on Oct 30, 2026.
Who are the largest shareholders of Gradiant?
According to the latest official filings, the largest reported holders are Lee Gi-hyeong (34.32%, as of Feb 27, 2026); State Street(R) SPDR(R) Portfolio Developed World ex-US ETF (0.45%, as of Jun 30, 2026); EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.41%, as of Jul 31, 2026).
When is the next earnings report from Gradiant?
Korean companies rarely announce results dates in advance. Based on when Gradiant filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

The company is a Korean holding-type business that supports and manages its subsidiaries and develops, manufactures and sells health functional foods. Its main segments are a holding business, industrial B2B e-commerce through brands such as iMarket Korea and Cube Bridge (selling consumables, raw materials, building materials and IT products), biohealthcare (prescription drugs and medical supplies through subsidiaries such as Ahn-Yeon Care and Terapex), and other businesses including logistics services. Its consolidated operations span Korea, Vietnam, China and other markets.

Written by AI from the company's latest annual report.

Korean name
그래디언트
Themes
—
CEO
이기형, 남인봉(각자 대표이사)
Founded
Oct 1997
Listed
Jul 1999
Listed shares
11,174,129
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Gradiant / 그래디언트 / 035080 / KRX:035080

Source: KRX statistical information